Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Vet Med Sci ; 8(5): 2067-2075, 2022 09.
Article in English | MEDLINE | ID: mdl-35981310

ABSTRACT

OBJECTIVES: Foot-and-mouth disease (FMD) is an economically important animal disease because of the speed of its transmission. Routine vaccination may not be effective; RAM can be considered as a potential facilitator for this. Present study was designed to evaluate the effects of feeding different treatment of the RAM in different days on the immune responses in mice immunised with FMDV type O vaccine. MATERIAL AND METHODS: In experiment 1, 50 ICR mice were randomly divided into five groups with 10 animals in each group, and the basic diet containing 1% Crush of RAM for 1-week ad libitum feeding period, 1% Crush of RAM for 6-week ad libitum feeding period, 1% Decoction of RAM for a 1-week ad libitum feeding period, 1% Decoction of RAM for a 6-week ad libitum feeding period, respectively. Blood samples were collected 2 weeks after boosting for measurement of FMDV-specific IgG level and the IgG subclasses, lymphocyte proliferation as well as production IL-5 and IFN-γ. In experiment 2, four groups mice were fed basic diet and basic diet containing 5% Decoction of RAM for 2-, 4- and 6-day ad libitum feeding periods, respectively. Then we collected blood samples for detecting IgG and IgG subclasses, splenocytes for lymphocyte proliferation as well as production IL-5 and IFN-γ, and tissue samples of small intestine for sIgA. RESULTS: The results indicated that 1% Decoction of RAM for a 1-week ad libitum feeding period group and 5% Decoction of RAM for 2-, 4- and 6-day ad libitum feeding period group enhance the FMDV-specific immune responses significantly. CONCLUSIONS: Taken together, the results demonstrate that doses and feeding time of RAM are important to affect the immune responses.


Subject(s)
Atractylodes , Foot-and-Mouth Disease Virus , Foot-and-Mouth Disease , Rodent Diseases , Viral Vaccines , Animals , Foot-and-Mouth Disease/prevention & control , Immunity , Immunoglobulin A, Secretory , Immunoglobulin G , Interleukin-5 , Mice , Mice, Inbred ICR , Plant Extracts
2.
Carbohydr Polym ; 91(1): 68-73, 2013 Jan 02.
Article in English | MEDLINE | ID: mdl-23044106

ABSTRACT

Fifty-six mice were randomly divided into four groups with 14 mice in each. Two groups were subcutaneously injected twice with a foot-and-mouth disease vaccine with 2-week intervals; each of them had been orally administered 0.89% saline or Atractylodis macrocephalae Koidz. polysaccharides (RAMPS) 0.05 g for 4 days before immunization. The rest were not immunized but treated in the same way. One-week after the primary and two weeks after the booster immunization, half in each group were sacrificed to measure serum IgG and the parameters for the intestinal mucosal immunity. Results indicated that oral administration of RAMPS increased both serum specific IgG response and intestinal mucosal immunity as shown by elevated total sIgA, mRNA expression of TGF-ß, IL-6, TNF-α, IgA(+) cells and intestinal intraepithelial lymphocytes in duodenum. It is suggested that increased serum IgG response may be associated with enhanced local mucosal immunity by oral administration of RAMPS.


Subject(s)
Atractylodes/chemistry , Immunoglobulin G/blood , Immunologic Factors/pharmacology , Intestinal Mucosa/drug effects , Intestinal Mucosa/immunology , Polysaccharides/pharmacology , Administration, Oral , Animals , Antibody Specificity , Cell Count , Cytokines/genetics , Duodenum/drug effects , Duodenum/immunology , Duodenum/metabolism , Female , Foot-and-Mouth Disease Virus/immunology , Gene Expression Regulation/drug effects , Immunity/drug effects , Immunoglobulin A/metabolism , Immunoglobulin G/immunology , Immunologic Factors/administration & dosage , Intestinal Mucosa/metabolism , Lymphocytes/cytology , Lymphocytes/drug effects , Lymphocytes/immunology , Mice , Mice, Inbred ICR , Polysaccharides/administration & dosage , RNA, Messenger/genetics , RNA, Messenger/metabolism
3.
Microbiol Immunol ; 54(1): 31-7, 2010.
Article in English | MEDLINE | ID: mdl-20055940

ABSTRACT

The extract from ECMS was investigated for its effect on the humoral immune responses to foot-and-mouth disease vaccination. Fifty-six mice were randomly divided into seven groups with eight animals in each. Mice in groups 5 to 7 were subcutaneously (s.c.) injected with 0.5 mg DEX daily for 4 days to induce immunosuppression. The animals were then orally given ECMS (200 microg in 250 microl saline) in groups 3 and 6 or 250 microl saline in group 2, or s.c. injected with ECMS (50 microg in 100 microl saline) in groups 4 and 7 or 100 microl saline in group 5. After that, the animals in groups 2 to 7 were s.c. immunized twice with 100 microl of commercial oil-adjuvanted bivalent FMDV vaccine (serotypes O and Asia 1) at intervals of 21 days. Mice in group 1 received injection of 100 microl saline only. After 2 weeks, blood was sampled to determine FMDV-specific IgG and isotype IgG1, IgG2a, IgG2b and IgG3. Results indicated that oral administration or s.c. injection of ECMS augmented responses of specific IgG and most IgG isotypes. Giving ECMS tended to enhance serum-specific IgG and IgG isotype responses of mice immunosuppressed by s.c. injection of DEX. Considering the safety and immunomodulatory effect of ECMS in both normal and immunosuppressed mice demonstrated in the present study, this extract deserves further investigation to evaluate its potential in improving FMD vaccination in farm animals such as pigs, sheep and cattle.


Subject(s)
Foot-and-Mouth Disease Virus/immunology , Immunity, Humoral/drug effects , Magnoliopsida/chemistry , Plant Extracts/pharmacology , Seeds/chemistry , Viral Vaccines/immunology , Animals , Female , Immunoglobulin G/immunology , Mice , Mice, Inbred ICR , Plant Extracts/chemistry , Protein Isoforms/immunology
4.
Int Immunopharmacol ; 10(3): 351-6, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20034596

ABSTRACT

This study was designed to evaluate the adjuvant effect of ginsenoside Re isolated from the root of Panax ginseng on the immune responses elicited by split inactivated H3N2 influenza virus antigen in a mouse model. Forty-eight ICR mice were randomly distributed into six groups with 8 mice in each group. All animals were subcutaneously (s.c.) immunized twice on weeks 0 and 3 with 50 microg Re, inactivated H3N2 influenza virus antigen equivalent to 10 or 100 ng of hemogglutinin (HA) or inactivated H3N2 influenza virus antigen equivalent to 10 ng HA adjuvanted with Re (25, 50 or 100 microg). Two weeks after the boost, blood samples were collected for measurement of serum IgG, the IgG isotypes and HI titers. Splenocytes were separated for the detection of lymphocyte proliferation and production of IFN-gamma and IL-5 in vitro. Results showed that co-administration of Re significantly enhanced serum specific IgG, IgG1, IgG2a and IgG2b responses, HI titers, lymphocyte proliferation responses as well as IFN-gamma and IL-5 secretions, indicating that both Th1 and Th2 were activated. Considering the adjuvant effect demonstrated in this study, Re deserve further studies for improving the quality of vaccines where mixed Th1/Th2 immune responses are needed.


Subject(s)
Adjuvants, Immunologic , Ginsenosides/pharmacology , Influenza A Virus, H3N2 Subtype/immunology , Influenza Vaccines/immunology , Animals , Cell Proliferation/drug effects , Female , Hemagglutination Inhibition Tests , Immunization , Immunoglobulin G/biosynthesis , Interferon-gamma/biosynthesis , Interleukin-5/biosynthesis , Lymphocytes/drug effects , Lymphocytes/immunology , Mice , Mice, Inbred ICR , Spleen/cytology , Spleen/drug effects , Spleen/immunology , Th1 Cells/drug effects , Th1 Cells/immunology , Th2 Cells/drug effects , Th2 Cells/immunology
5.
Vaccine ; 27(15): 2094-8, 2009 Mar 26.
Article in English | MEDLINE | ID: mdl-19356611

ABSTRACT

This study was designed to evaluate the effects of oral administration of a water extract made from the Rhizoma Atractylodis Macrocephalae (RAM) on the immune responses in mice immunized with FMDV type O vaccine. Thirty-five ICR mice were randomly divided into five groups with seven animals in each group, and orally administered daily for 4 days at a dose equivalent to 0, 0.0625, 0.125, 0.25 or 0.5 g of dried RAM, respectively. After that, the animals were subcutaneously immunized twice with FMDV vaccine at 2-week intervals. Blood samples were collected 3 weeks after boosting for measurement of FMDV-specific IgG titers and the IgG subclasses, lymphocyte proliferation as well as production IL-5 and IFN-gamma. Results indicated that serum FMDV-specific IgG titers and the IgG subclass responses were significantly enhanced in mice orally administered RAM at the dose of 0.25 or 0.5 g when compared with the control group (P<0.05). Splenocyte proliferation in response to Con A and LPS and production of IL-5 and IFN-gamma by splenocytes were also significantly enhanced (P<0.05). Considering the immunomodulatory effect and safety of RAM demonstrated in this study, this herb deserves further investigation to evaluate its potential improvement of FMD vaccination in other animals such as pigs, goats and cattle.


Subject(s)
Foot-and-Mouth Disease Virus/immunology , Foot-and-Mouth Disease/immunology , Plant Extracts/immunology , Viral Vaccines/immunology , Animals , Antibodies, Viral/blood , Antibodies, Viral/immunology , Cell Proliferation , Female , Foot-and-Mouth Disease/prevention & control , Immunoglobulin G/blood , Immunoglobulin G/immunology , Interferon-gamma/biosynthesis , Interferon-gamma/immunology , Interleukin-5/biosynthesis , Interleukin-5/immunology , Mice , Mice, Inbred ICR , Plant Extracts/administration & dosage , Random Allocation , Spleen/immunology , Spleen/metabolism , Viral Vaccines/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...